In December 2017 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the wrestler Shri Bhagwan after his sample tested positive for the prohibited substances 19-norandrosterone (Nandrolone) and Meldonium.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete stated that he had used prescribed medication as treatment for his injury. Here he failed to apply for a TUE nor did he mention his medication on the Doping Control Form.
The Panel did not accept the Athlete’s statement and evidence as it does not explain the presence of Meldonium in his sample. The Panel deems that the Athlete failed to establish that the violation was not intentional nor how the substance entered his system.
Therefore the ADDPI decides on 15 October 2018 to impose a 4 year period of ineligibility on the Athlete starting on de date of the provisional suspension, i.e. on 12 December 2018.
